James A. Balschi
University of Alabama at Birmingham
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James A. Balschi.
Biophysical Journal | 1982
James A. Balschi; Vincent P. Cirillo; Charles S. Springer
A new nuclear magnetic resonance (NMR) method for monitoring transmembrane metal cation transport is reported. It is illustrated with a study of Na(+) efflux from Na(+)-rich yeast cells. The technique involves the use of an anionic paramagnetic shift reagent, present only outside the cells, to induce a splitting of the sodium-23 NMR peak, in this case, into components representing intra- and extracellular Na(+). The time course of the efflux is in good agreement with the literature and can be well fitted with a double exponential decay expression. Splitting of the lithium-7 NMR signal from a suspension of Li(+)-rich respiratory-deficient, petite yeasts is also reported.
Circulation | 1996
Ingrid M. Straeter-Knowlen; William T. Evanochko; Jan A. den Hollander; Paul E. Wolkowicz; James A. Balschi; James B. Caulfield; David D. Ku; Gerald M. Pohost
BACKGROUND Myocardial ischemic insult causes depression of fatty-acid beta-oxidation and increased fatty-acid esterification with triglyceride (TG) accumulation. This accumulation has been demonstrated to occur in the territory with diminished blood flow surrounding an infarct, ie, the region at risk. To evaluate whether the extent of TG accumulation in the canine heart after 24 hours of ischemia could be detected, we applied myocardial 1H nuclear magnetic resonance (NMR) spectroscopic imaging (SI). METHODS AND RESULTS Seven adult mongrel dogs underwent 24 hours of left anterior descending coronary artery occlusion. Postmortem, the hearts were excised and the size and location of the infarct were determined. With a Philips 1.5-T clinical NMR imaging/spectroscopic system, two-dimensional (2D) 1H NMR SI was performed. TG 1H NMR chemical shift images were reconstructed from the frequency domain spectra by numerical integration. A statistically significant (P < .05) increase in TG signal intensity was demonstrated in the region at risk compared with the nonischemic control region. There was an intermediate quantity of TG in the infarct region. Biochemical determination of tissue TG content (milligrams per gram wet weight) in the control, at-risk, and infarct regions confirmed the 1H NMR measurements. Histological evaluation with oil red O staining also demonstrated graded TG accumulation in myocytes. The highest TG levels were found in the at-risk region and the lowest levels in the control region. CONCLUSIONS By use of 2D 1H NMR SI, the present study confirms and extends previous work that demonstrates preferential accumulation of TG in the reversibly injured myocardium after 24 hours of coronary occlusion. This study provides an important step toward the clinical application of TG imaging. When TG imaging is ultimately possible, resultant data would have diagnostic, prognostic, and therapeutic implications.
Journal of Cardiovascular Magnetic Resonance | 2001
Hai Shen; James A. Balschi; Gerald M. Pohost; Paul E. Wolkowicz
PURPOSE Triacylglycerol (TAG) lipolysis increases in diabetic hearts. However, it is not known which pathway for lipolysis catalyzes this process. Thus, using 1H-magnetic resonance spectroscopy (MRS), we determined whether TAG lipolysis in diabetic rat hearts requires acid lipase or neutral lipase activity. METHODS Rats were given IP injections of 110 mg streptozotocin (STZ)/kg. Forty-eight to 72 h after this treatment, all rats exhibited ketotic diabetes. The hearts of these ketotic rats were isolated, perfused isovolumically, and analyzed using 1H-MRS. RESULTS The content of methylene protons (CH2)n--and otherfatty acid protons, measured using 1H-MRS, increased in hearts isolatedfrom STZ-treated compared to untreated rats. This increase in heart--(CH2)n--was directly related to the chemical content of heart TAGs. If isolated diabetic hearts were perfused with either glucose or glucose plus the acid lipase inhibitor methylamine, then heart content of TAG, measured as (CH2)n, decreased at rates of approximately 130 nmol TAG/gdw/min throughout a 55-min perfusion. If diabetic hearts were pretreated with the neutral lipase inhibitor diethyl-p-nitro-phenylphosphate (DNPP) and perfused with glucose, then heart TAG content, measured as (CH2)n, did not change during perfusion. CONCLUSIONS 1H-MRS can detect the TAG and the net lipolysis of TAG in diabetic rat hearts. Net TAG lipolysis in diabetic rat hearts requires neutral lipase.
American Journal of Physiology-heart and Circulatory Physiology | 2003
Maurits A. Jansen; Hai Shen; Li Zhang; Paul E. Wolkowicz; James A. Balschi
NMR in Biomedicine | 1993
Mitchell S. Albert; Wei Huang; Jing-Huei Lee; James A. Balschi; Charles S. Springer
Journal of Molecular and Cellular Cardiology | 1997
James A. Balschi; Jenny O. Hai; Paul E. Wolkowicz; Ingrid M. Straeter-Knowlen; William T. Evanochko; James B. Caulfield; Edwin L. Bradley; David D. Ku; Gerald M. Pohost
Magnetic Resonance in Medicine | 1990
Yan Xu; James A. Balschi; Charles S. Springer
NMR in Biomedicine | 1995
James A. Balschi; Hoby P. Hetherington; Gerald M. Pohost; Edwin L. Bradley
Journal of Molecular and Cellular Cardiology | 1997
James A. Balschi; Hai Shen; Michael C. Madden; Jenny O. Hai; Edwin L. Bradley; Paul E. Wolkowicz
ChemInform | 1983
Martin M. Pike; David M. Yarmush; James A. Balschi; Robert E. Lenkinski; Charles S. Springer